|
1
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nusse R and Clevers H: Wnt/β-catenin
signaling, disease, and emerging therapeutic modalities. Cell.
169:985–999. 2017.
|
|
3
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cruciat CM and Niehrs C: Secreted and
transmembrane wnt inhibitors and activators. Cold Spring Harb
Perspect Biol. 5(a015081)2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Farooqi AA, de la Roche M, Djamgoz MBA and
Siddik ZH: Overview of the oncogenic signaling pathways in
colorectal cancer: Mechanistic insights. Semin Cancer Biol.
58:65–79. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liu TH, Raval A, Chen SS, Matkovic JJ,
Byrd JC and Plass C: CpG island methylation and expression of the
secreted frizzled-related protein gene family in chronic
lymphocytic leukemia. Cancer Res. 66:653–658. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rubin JS and Bottaro DP: Loss of secreted
frizzled-related protein-1 expression in renal cell carcinoma
reveals a critical tumor suppressor function. Clin Cancer Res.
13:4660–4663. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chong JM, Uren A, Rubin JS and Speicher
DW: Disulfide bond assignments of secreted frizzled-related
protein-1 provide insights about frizzled homology and netrin
modules. J Biol Chem. 277:5134–5144. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Deshmukh A, Arfuso F, Newsholme P and
Dharmarajan A: Epigenetic demethylation of sFRPs, with emphasis on
sFRP4 activation, leading to Wnt signalling suppression and histone
modifications in breast, prostate, and ovary cancer stem cells. Int
J Biochem Cell Biol. 109:23–32. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pawar NM and Rao P: Secreted frizzled
related protein 4 (sFRP4) update: A brief review. Cell Signal.
45:63–70. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pohl S, Scott R, Arfuso F, Perumal V and
Dharmarajan A: Secreted frizzled-related protein 4 and its
implications in cancer and apoptosis. Tumour Biol. 36:143–152.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Qi J, Zhu YQ, Luo J and Tao WH:
Hypermethylation and expression regulation of secreted
frizzled-related protein genes in colorectal tumor. World J
Gastroenterol. 12:7113–7117. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Michalak EM, Burr ML, Bannister AJ and
Dawson MA: The roles of DNA, RNA and histone methylation in ageing
and cancer. Nat Rev Mol Cell Biol. 20:573–589. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dor Y and Cedar H: Principles of DNA
methylation and their implications for biology and medicine.
Lancet. 392:777–786. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schübeler D: Function and information
content of DNA methylation. Nature. 517:321–326. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Samaei NM, Yazdani Y, Alizadeh-Navaei R,
Azadeh H and Farazmandfar T: Promoter methylation analysis of
WNT/β-catenin pathway regulators and its association with
expression of DNMT1 enzyme in colorectal cancer. J Biomed Sci.
21(73)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Takeshima H, Wakabayashi M, Hattori N,
Yamashita S and Ushijima T: Identification of coexistence of DNA
methylation and H3K27me3 specifically in cancer cells as a
promising target for epigenetic therapy. Carcinogenesis.
36:192–201. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ning X, Shi Z, Liu X, Zhang A, Han L,
Jiang K, Kang C and Zhang Q: DNMT1 and EZH2 mediated methylation
silences the microRNA-200b/a/429 gene and promotes tumor
progression. Cancer Lett. 359:198–205. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sarma DP: The Dukes classification of
colorectal cancer. JAMA. 256(1447)1986.PubMed/NCBI
|
|
20
|
Coppedè F: Epigenetic biomarkers of
colorectal cancer: Focus on DNA methylation. Cancer Lett.
342:238–247. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Baharudin R, Tieng FYF, Lee LH and Ab
Mutalib NS: Epigenetics of SFRP1: The dual roles in human cancers.
Cancers (Basel). 12(445)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu R, Su X, Long Y, Zhou D, Zhang X, Ye
Z, Ma J, Tang T, Wang F and He C: A systematic review and
quantitative assessment of methylation biomarkers in fecal DNA and
colorectal cancer and its precursor, colorectal adenoma. Mutat Res.
779:45–57. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Vincent KM and Postovit LM: Matricellular
proteins in cancer: A focus on secreted frizzled-related proteins.
J Cell Commun Signal. 12:103–112. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Walters ZS, Villarejo-Balcells B, Olmos D,
Buist TW, Missiaglia E, Allen R, Al-Lazikani B, Garrett MD, Blagg J
and Shipley J: JARID2 is a direct target of the PAX3-FOXO1 fusion
protein and inhibits myogenic differentiation of rhabdomyosarcoma
cells. Oncogene. 33:1148–1157. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang Q, Huang T, Ye G, Wang B and Zhang X:
Methylation of SFRP2 gene as a promising noninvasive biomarker
using feces in colorectal cancer diagnosis: A systematic
meta-analysis. Sci Rep. 6(33339)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Suzuki H, Watkins DN, Jair KW, Schuebel
KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van
Engeland M, et al: Epigenetic inactivation of SFRP genes allows
constitutive WNT signaling in colorectal cancer. Nat Genet.
36:417–422. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Stoll S, Wang C and Qiu H: DNA methylation
and histone modification in hypertension. Int J Mol Sci.
19(1174)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang W, Qin JJ, Voruganti S, Nag S, Zhou J
and Zhang R: Polycomb group (PcG) proteins and human cancers:
Multifaceted functions and therapeutic implications. Med Res Rev.
35:1220–1267. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chan HL and Morey L: Emerging roles for
polycomb-group proteins in stem cells and cancer. Trends Biochem
Sci. 44:688–700. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Piunti A and Shilatifard A: Epigenetic
balance of gene expression by polycomb and COMPASS families.
Science. 352(aad9780)2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Colón-Caraballo M, Monteiro JB and Flores
I: H3K27me3 is an epigenetic mark of relevance in endometriosis.
Reprod Sci. 22:1134–1142. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu M, Zhou J, Chen Z and Cheng ASL:
Understanding the epigenetic regulation of tumours and their
microenvironments: Opportunities and problems for epigenetic
therapy. J Pathol. 241:10–24. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bogdanovic O, Long SW, van Heeringen SJ,
Brinkman AB, Gómez-Skarmeta JL, Stunnenberg HG, Jones PL and
Veenstra GJ: Temporal uncoupling of the DNA methylome and
transcriptional repression during embryogenesis. Genome Res.
21:1313–1327. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Emran AA, Chatterjee A, Rodger EJ, Tiffen
JC, Gallagher SJ, Eccles MR and Hersey P: Targeting DNA methylation
and EZH2 activity to overcome melanoma resistance to immunotherapy.
Trends Immunol. 40:328–344. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen JF, Luo X, Xiang LS, Li HT, Zha L, Li
N, He JM, Xie GF, Xie X and Liang HJ: EZH2 promotes colorectal
cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin
signaling. Oncotarget. 7:41540–41558. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS,
Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al: EZH2-mediated
concordant repression of Wnt antagonists promotes
β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71:4028–4039.
2011.
|
|
38
|
Chen Q, Zheng PS and Yang WT:
EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin
signaling-dependent cell expansion in cervical carcinoma.
Oncotarget. 7:36115–36129. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ma R, Wei Y, Huang X, Fu R, Luo X, Zhu X,
Lei W, Fang J, Li H and Wen W: Inhibition of GSK 3β activity is
associated with excessive EZH2 expression and enhanced tumour
invasion in nasopharyngeal carcinoma. PLoS One.
8(e68614)2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Clermont PL, Lin D, Crea F, Wu R, Xue H,
Wang Y, Thu KL, Lam WL, Collins CC, Wang Y and Helgason CD:
Polycomb-mediated silencing in neuroendocrine prostate cancer. Clin
Epigenetics. 7(40)2015.PubMed/NCBI View Article : Google Scholar
|
